Sant Pau - Institut de Recerca

Main lines of research

Bone Metabolism and Osteoporosis

Analysis of genetic influence on osteoporosis by means of aggregation studies in families of three or more generations with a minimum of 15 members.
Bone structure study with quantitative CT of hip and spine, analysing the contribution of trabecular and cortical components using HRCT.
Description of fat values and percentages in a normal population (in collaboration with the HIV Unit and CETIR Medical Group).
Analysis of the influence of an intervention (physical exercise) on changes in the muscle compartment of patients with cirrhosis measured by DXA and HRQCT (in collaboration with the Gastroenterology Department).
Description of bone structure in patients with a history of acromegaly assessed by DXA and HRQCT.

Hypertension and Vascular Risk

Hypertension and quality of life.
Refractory hypertension.
Use of alirocumab in hypercholesterolaemia.

Clinical Management, Internal Medicine and Geriatrics

Health care quality indexes (mortality, readmissions, etc).
Perioperative medicine.
Potentially inappropriate prescribing to older patients admitted to hospital.

Rheumatology and Rheumatoid Arthritis

Early rheumatoid arthritis
Rheumatoid arthritis biomarkers
Interstitial lung disease associated with rheumatoid arthritis

Systemic sclerosis

Capillaroscopy patterns and correlation with auto-antibodies and pulmonary function tests.
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
Use of endothelin receptor antagonism to prevent pulmonary arterial hypertension (in collaboration with Vall d’Hebron University Hospital, Barcelona, Spain).
Genetic studies in systemic sclerosis and collaboration with DUO Registry and LAUDES study.
Study of capillaroscopy patterns in diffuse connective tissue diseases: QuantiCAP study.

Gout

Epidemiology of hyperuricaemia and gout.

Sjögren syndrome

TClinical and epidemiological findings in Spanish patients with primary Sjögren syndrome (in collaboration with Spanish Society of Rheumatology).

Challenges

To establish stable work relations between the HSCSP Bone Metabolism and Genomics of Complex Diseases Groups and the Bone Metabolism Unit of Hospital del Mar-Municipal Institute for Medical Research and the Faculty of Biology of the University of Barcelona.
To strengthen ties between Sant Pau’s Rheumatology and Immunology departments regarding the study of immunological diseases.

Group coordination

COROMINAS MACIAS, HECTOR FGS
hcorominas@santpau.cat

Members

Arroyo Diaz, Juan Antonio FGS
Barcelo Trias, Montserrat FGS
Bernardez Moreno, Julia IR
Casademont Pou, Jordi FGS
Castellvi Barranco, Ivan FGS
Codes Mendez, Helena FGS
Diaz Torne, Cesar FGS
Dutren Tella, Adriana IR
Garcia Alija, Asier FGS
Hernandez de Sosa, Nerea FGS
Laiz Alonso, Ana Maria FGS
Magallares Lopez, Berta Paula FGS
Moya Alvarado, Patricia FGS
Sainz Comas, Luis FGS
Santos Gutierrez, Alvaro FGS
Sihuro Cervantes, Margarita IR
Tandaipan Jaime, Jose Luis FGS
Torres Bonafonte, Olga Herminia FGS

Publications 2023

(JIF 2023)

-Balsa A, Díaz Del Campo Fontecha P, Silva L, Valencia J, Nistal V, León F, Hernández MV, Corominas H, Cáliz R, Aguado JM, Candelas G, Ibargoyen N, Martí A, Plana MN, Puñal J, Park HS, Triñanes Y, Villaverde V. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatologia Clinica. 2023; 19(10). DOI:10.1016/j.reumae.2023.07.004. PMID:38008602. IF:1,200 (Q4/8D). Document type: Article.

-Barceló M, Casademont J, Mascaró J, Gich I, Torres OH. Indoor falls and number of previous falls are independent risk factors for long-term mortality after a hip fracture. AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2023; 35(11). DOI:10.1007/s40520-023-02551-3. PMID:37688755. IF:3,400 (Q2/5D). Document type: Article.

-Boleto G, Reiseter S, Hoffmann AM, Mirouse A, Cacoub P, Matucci M, Silvério M, Fonseca JE, Duarte AC, Pestana J, Riccieri V, Lescoat A, Le E, Castellví I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 63:152258. DOI:10.1016/j.semarthrit.2023.152258. PMID:37696231. IF:4,600 (Q1/2D). Document type: Article.

-Casademont J. Physical examination today. MEDICINA CLINICA. 2023; 160(12). DOI:10.1016/j.medcli.2023.02.001. PMID:36907715. IF:2,600 (Q1/3D). Document type: Editorial Material.

-Colalillo A, Hoffmann A-M, Pellicano C, Romaniello A, Gabrielli A, Hachulla E, Smith V, Simeón C-P, Castellví I, Airò P, Truchetet M-E, Siegert E, Distler O, Rosato E, the C. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4):103290. DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9,200 (Q1/1D). Document type: Review.

-Corominas H, Young D, Cummings JRF, Bouhnik Y, Armuzzi A, Thaci D, Kim J. Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. CLINICAL DRUG INVESTIGATION. 2023; 43(8). DOI:10.1007/s40261-023-01284-5. PMID:37615857. IF:2,900 (Q2/5D). Document type: Review.

-Díaz C, Pou MA, Rodríguez B, Pujol E. Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups. Reumatologia Clinica. 2023; 19(3). DOI:10.1016/j.reuma.2022.03.009. PMID:36058814. IF:1,200 (Q4/8D). Document type: Article.

-Hernández N, Cardona R, Casademont J. A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses. AMERICAN JOURNAL OF CASE REPORTS. 2023; 24:e938548. DOI:10.12659/AJCR.938548. PMID:36841939. IF:1,000 (Q3/6D). Document type: Article.

-Jeria S, Gomez A, Park HS, Calvo E, Corominas H, Pou MA, Diaz C. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9:1089993. DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3,100 (Q1/2D). Document type: Article.

-Morillon MB, Norup A, Singh JA, Dalbeth N, Taylor WJ, Kennedy MA, Pedersen BM, Grainger R, Tugwell P, Perez F, Diaz C, Edwards NL, Shea B, Ellingsen TJ, Christensen R, Stamp LK, OMERACT Gout Working GRP. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 60:152191. DOI:10.1016/j.semarthrit.2023.152191. PMID:36963128. IF:4,600 (Q1/2D). Document type: Article.

-Narváez J, Aburto M, Seoane D, Bonilla G, Acosta O, Candelas G, Cano E, Castellví I, González JM, Corominas H, López B, Martín M, Robles A, Mena N, Rodríguez JA, Ortiz AM, Sabater C, Castrejón I, dos R, Garrote S, Maese J, Silva L, Castañeda S, Valenzuela C. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2). DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:1,200 (Q4/8D). Document type: Article.

-Osuna R, Castellvi I, Mulet M, Ortiz MA, Brough DE, Sabzevari H, Semnani RT, Vidal S. Impaired Regulation by IL-35 in Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13):10567. DOI:10.3390/ijms241310567. PMID:37445745. IF:4,900 (Q1/3D). Document type: Article.

-Oteo JA, Corominas H, Escudero R, Fariñas F, García JC, Goenaga MA, Guillén S, Mascaró JM, Portillo A. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1). DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2,600 (Q3/6D). Document type: Article.

-Pombo M, Seoane D, Diaz F, Cea L, Sanchez F, Sanchez M, Jovani V, Garcia B, Martinez O, Campos C, Manero J, Diaz C, Bohorquez C, Ros I, Perez Y, Castrejon I. Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis. Musculoskeletal Care. 2023; 21(1). DOI:10.1002/msc.1684. PMID:35996810. IF:1,500 (Q3/7D). Document type: Article.

-Popova E, Paniagua P, Álvarez J, Vives M, González A, García Á, Rivas M, Hermenegildo G, Diaz R, Azparren G, Barceló M, Moustafa A-H, Aguilar R, Ordonez J, Alonso P. The Relevance of Implementing the Systematic Screening of Perioperative Myocardial Injury in Noncardiac Surgery Patients. Journal of Clinical Medicine. 2023; 12(16):5371. DOI:10.3390/jcm12165371. PMID:37629413. IF:3,000 (Q1/2D). Document type: Article.

-Pou MA, Martinez D, Estebanez JL, Aivar M, Gayarre R, Conesa A, Hoyo J, Carbonell C, Reyes C, Diaz C. Validation of gout diagnosis in electronic primary care medical records: A population-based study. JOINT BONE SPINE. 2023; 90(6):105628. DOI:10.1016/j.jbspin.2023.105628. PMID:37634875. IF:3,800 (Q1/3D). Document type: Article.

-Queiro R, Seoane D, Laiz A, Agirregoikoa EG, Montilla C, Park HS, Pinto JA, Bethencourt JJ, Ibáñez BJ, Toniolo E, Ramírez J, Marcos AG. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1). DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3,400 (Q2/3D). Document type: Article.

-Queiro R, Seoane D, Laiz A, Galindez E, Montilla C, Park HS, Tasende JAP, Baute JJB, Joven B, Toniolo E, Ramírez J, Montero N, Pruenza García C, Serrano A, on behalf of the Proyecto REAPSER Study G. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3):931. DOI:10.3390/jcm12030931. PMID:36769579. IF:3,000 (Q1/2D). Document type: Article.

-Sainz L, Riera P, Moya P, Bernal S, Casademont J, Díaz C, Millán AM, Park HS, Lasa A, Corominas H. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1):61. DOI:10.3390/jpm13010061. PMID:36675722. IF:3,000 (Q1/2D). Document type: Article.

-Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz C, Millan AM, Park HS, Lasa A, Corominas H. Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2023; 25(1):226. DOI:10.1186/s13075-023-03209-1. PMID:38001504. IF:4,400 (Q1/3D). Document type: Article.

-Sanmarti R, Corominas H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5):1734. DOI:10.3390/jcm12051734. PMID:36902522. IF:3,000 (Q1/2D). Document type: Review.

-Tandaipan J, Guillén A, Simeón CP, Carreira PE, De la Puente C, Narváez J, Lluch J, Rubio M, Alegre JJ, Bonilla G, Moriano C, Casafont I, García R, Ortiz V, Riera E, Atienza B, Blanco R, Galisteo C, Gonzalez JJ, Pego JM, Pros A, Heredia S, Castellví I. Immunoglobulins in systemic sclerosis management. A large multicenter experience. AUTOIMMUNITY REVIEWS. 2023; 22(11):103441. DOI:10.1016/j.autrev.2023.103441. PMID:37708984. IF:9,200 (Q1/1D). Document type: Article.

-Valero C, Urgelles JF, Sallés M, Joven BE, de Juanes A, Ramírez J, Juanola X, Almodóvar R, Laiz A, Moreno M, Pujol M, Beltrán E, Pinto JA, Crespí L, Sala L, Castañeda S, García R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14:1283251. DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5,700 (Q1/3D). Document type: Article.

-Vallez L, Gasó I, Marcos Á, Garrido G, Riera A, Plaza A, Martinez C, Mangues MA, Corominas H. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2,900 (Q2/4D). Document type: Article.

Publications 2022

(JIF 2022)

Alvarado PM, de Oro JJD, Espinar MA, Perez EA, Perez NB, Carmona L, Burgos EC, Poch TC, Aguilera AC, Mendieta ED, Alarcon PE, Casares EG, Perez SH, Lopez BM, Morillo MM, Soria LM, Pastor CM, Martinez MM, Fernandez AP, Busquets MP, Garcia JR, Sanz DR, Lizarzaburu MS, Santo Panero P, Alierta ES, Roc MV, Macias HC. Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists. RHEUMATOLOGY INTERNATIONAL. 2022; 42(3). DOI:10.1007/s00296-020-04733-y. PMID:33146762. IF:4 (Q2/5D). Document type: Article.
Balius R, Pujol M, Perez D, Morros C, Susin A, Corominas H, Sala X. Sciatic nerve movement in the deep gluteal space during hip rotations maneuvers. CLINICAL ANATOMY. 2022; 35(4). DOI:10.1002/ca.23828. PMID:34913517. IF:2,4 (Q2/4D). Document type: Article.
Balsa A, González I, Sanmartí R, Corominas H. How do Spanish Rheumatologists handle remission? Survey of knowledge and approach before and after a training workshop. Reumatologia Clinica. 2022; 18(9). DOI:10.1016/j.reuma.2021.08.002, DOI (English Edition):10.1016/j.reumae.2021.08.002. PMID:34489191. Document type: Letter.
Calabria M, Garcia C, Grunden N, Pons C, Arroyo JA, Gomez B, Garcia M, Belvis R, Morollon N, Igual JV, Mur I, Pomar V, Domingo P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. JOURNAL OF NEUROLOGY. 2022; 269(8). DOI:10.1007/s00415-022-11141-8. PMID:35488918. IF:6 (Q1/2D). Document type: Article.
Calvo J, Pou J. Continuing medical education. An opportunity to continue improving. MEDICINA CLINICA. 2022; 159(1). DOI:10.1016/j.medcli.2022.03.012. PMID:35636993. IF:3,9 (Q2/4D). Document type: Editorial material.
Castellvi I, Castillo D, Corominas H, Mariscal A, Orozco S, Benito N, Pomar V, Baucells A, Mur I, de la Rosa D, Lobo D, Millan AM, de Sosa NH, Filella D, Matas L, Martinez L, Juarez C, Casademont J, Domingo P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9:973918. DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3,9 (Q2/4D). Document type: Article.
Castellví I, Vidal S, Valenzuela C. Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8). DOI:10.1016/j.arbres.2021.08.016. PMID:35312568. IF:8 (Q1/2D). Document type: Editorial material.
Cendon L, Rafecas A, De La Rosa D, Castellví I, Spagnolo P, Castillo D. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia. Open Respiratory Archives. 2022; 4(4):100211. DOI:10.1016/j.opresp.2022.100211. Document type: Article.
Cobo T, Sánchez C, Nuño L, Castellví I, Carrión I, Romero F, Narváez J, Trallero E, Tomero E, Ruiz ME, Larena C, Carrasco C, Jovaní V, Barbadillo C, Sivera F, Belzunegui J, Pérez A, Gómez A, Delgado E, Pego JM, Joven B, Ibáñez M, Martínez O, Ruiz A, Camins J, Ortega R, Trenor P, Rodríguez M, Freire M, Alcocer P, Holgado S, Rúa I, Lozano N, Martínez J. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatologia Clinica. 2022; 18(5). DOI:10.1016/j.reuma.2021.01.007. PMID:33867271. Document type: Article.
de la Calle C, Rodriguez J, Ciudad L, Ramirez J, Celis R, Azuaga AB, Cuervo A, Graell E, Perez C, Diaz C, Salvador G, Gomez JA, Haro I, Sanmarti R, Canete JD, Ballestar E. The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis. JCI Insight. 2022; 7(9):e158783. DOI:10.1172/jci.insight.158783. PMID:35324478. IF:8 (Q1/2D). Document type: Article.
De Miguel E, Sanchez JT, Estrada P, Munoz A, Martinez CV, Alvarado PM, Garcia MJ, Angeles V, Da CGL, Frutos AR, Ivorra J, Arrabal SL, Rocha MV, Iniguez CL, Garcia M, Molina C, Villar MA, Mas AJ, Gonzalez MA, Blanco R. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register. RMD Open. 2022; 8(2):e002507. DOI:10.1136/rmdopen-2022-002507. PMID:36597988. IF:6,2 (Q1/2D). Document type: Article.
Fernández SP, Rodríguez F, Laiz A, Castellví I, Magallares B, Corominas H. Impact of the COVID-19 pandemic on rheumatology nursing consultation. Reumatologia Clinica. 2022; 18(4). DOI:10.1016/j.reuma.2021.02.003. PMID:34088653. Document type: Article.
Franco T, Torres OH, Saez ME, Boera G, Santos Á, Clotet S, Albert D, El Y, Agustí M, Casademont J, Juárez C, Martínez L. Early differentiated CD28(+) CD27(+) T lymphocytes as a biomarker for short and long-term outcomes in older patients with pneumonia. JOURNAL OF LEUKOCYTE BIOLOGY. 2022; 112(5). DOI:10.1002/JLB.5MA0422-370R. PMID:35748037. IF:5,5 (Q2/3D). Document type: Article.
Galindo R, Bou R, Mir C, Martínez S, Magallares B, López M. Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children. ANALES DE PEDIATRIA. 2022; 97(3). DOI:10.1016/j.anpedi.2021.09.008. PMID:35915035. IF:2,1 (Q3/6D). Document type: Article.
Garcia C, Calabria M, Grunden N, Pons C, Arroyo JA, Gomez B, Lleo A, Alcolea D, Belvis R, Morollon N, Mur I, Pomar V, Domingo P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain and Behavior. 2022; 12(3):e2508. DOI:10.1002/brb3.2508. PMID:35137561. IF:3,1 (Q2/3D). Document type: Article.
Gomez JA, Lobo D, Perez C, Ponce A, Frade B, Arciniegas A, Ojeda F, Ruiz V, Corominas H. Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study. Frontiers in Medicine. 2022; 9:888377. DOI:10.3389/fmed.2022.888377. PMID:35783644. IF:3,9 (Q2/4D). Document type: Article.
Hemmig AK, Gozzoli D, Werlen L, Ewald H, Aschwanden M, Blockmans D, Brouwer E, Buchanan RRC, Camellino D, Campochiaro C, Cimmino MA, Corominas H, Gloy V, Henckaerts L, Kyburz D, Moya P, Owen CE, Stegert M, Tomelleri A, van Y, Yamashita H, Imfeld S, Berger CT, Hemkens LG, Daikeler T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 55:152017. DOI:10.1016/j.semarthrit.2022.152017. PMID:35537222. IF:5 (Q2/3D). Document type: Review.
Hernández B, Rosas J, Díaz C, Belzunegui J, García R, Inciarte J, Pons A, Millán AM, Jeria S, Valero JA, García N, Valero C, Llorente I, Calvo A, Díaz S, Núñez M. Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study). Rheumatology and Therapy. 2022; 9(2). DOI:10.1007/s40744-021-00423-8. IF:3,8 (Q3/6D). Document type: Article.
Julia A, Gomez A, Lopez M, Blanco F, Erra A, Fernandez A, Mas AJ, Perez C, Vivar MLG, Sanchez S, Alperi M, Sanmarti R, Ortiz AM, Fernandez CM, Diaz C, Moreno E, Li TL, Martinez SH, Absher DM, Myers RM, Molina JT, Marsal S. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. 2022; 80:104053. DOI:10.1016/j.ebiom.2022.104053. PMID:35576644. IF:11,1 (Q1/1D). Document type: Article.
Kerick M, Acosta M, Simeón CP, Callejas JL, Assassi S, Carreira P, Castellvi I, Ríos R, Portales RG, Fernández A, García FJ, Aguirre MA, Fernández B, Rodríguez L, de la Peña PG, Vicente E, Andreu JL, de Castro MF, López FJ, Fonollosa V, Guillén A, Tolosa C, Pros A, Beltrán E, Carballeira MR, Narváez FJ, Rivas MR, Ortiz V, Madroñero AB, González MA, Díaz B, Trapiella L, et al., International SSC Group, Australian Scleroderma Interest Group, PRECISESADS Clinical Consortium. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. npj Genomic Medicine. 2022; 7(1):57. DOI:10.1038/s41525-022-00327-8. PMID:36198672. IF:5,3 (Q1/2D). Document type: Article.
Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, Vettori S, Siegert E, Rednic S, Codullo V, Airo P, Braun Y, Hunzelmann N, Joao M, Riccieri V, Gheorghiu A-M, Alegre JJ, Romanowska K, Castellví I, Kötter I, Truchetet M-E, López FJ, Novikov PI, Giollo A, Shirai Y, Belloli L, Zanatta E, Hachulla E, Smith V, Denton C, Ionescu RM, Schmeiser T, Distler JHW, Gabrielli A, Hoffmann A-M, Kuwana M, Allanore Y, Distler O. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open. 2022; 8(2):e002477. DOI:10.1136/rmdopen-2022-002477. PMID:36328401. IF:6,2 (Q1/2D). Document type: Article.
Lopez A, Laiz A, Puig L. Psoriatic arthritis. MEDICINA CLINICA. 2022; 159(1). DOI:10.1016/j.medcli.2022.01.024. PMID:35525675. IF:3,9 (Q2/4D). Document type: Review.
Mariscal A, Zamora C, Diaz C, Ortiz MA, de Agustin JJ, Reina D, Estrada P, Moya P, Corominas H, Vidal S. Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(10):5748. DOI:10.3390/ijms23105748. PMID:35628558. IF:5,6 (Q1/3D). Document type: Article.
Marquès M, Correig E, Ibarretxe D, Anoro E, Antonio J, Jericó C, Borrallo RM, Miret M, Näf S, Pardo A, Perea V, Pérez R, Ramírez R, Royuela M, Soler C, Urquizu M, Zamora A, Pedro J, Masana L, Domingo JL, STACOV G. Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality. ENVIRONMENT INTERNATIONAL. 2022; 158:106930. DOI:10.1016/j.envint.2021.106930. PMID:34678637. IF:11,8 (Q1/1D). Document type: Article.
Martin JL, Sanchez L, Calvo V, Adan A, Hernanz I, Gallego A, Beltran E, Castro S, Fanlo P, Martos AG, Torre I, Cordero M, De Dios JR, Garcia A, Hernandez M, Sanchez A, Garcia A, Maiz O, Miguelez R, Rodriguez S, Urruticoechea A, Veroz R, Conesa A, Fernandez C, Jovani V, Mondejar JJ, Gonzalez OM, Alvarado PM, Romero S, Rubio P, Pena E, Garijo M, Demetrio R, Hernandez JL, Blanco R. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients. RMD Open. 2022; 8(2):e002693. DOI:10.1136/rmdopen-2022-002693. PMID:36597972. IF:6,2 (Q1/2D). Document type: Article.
Masana L, Correig E, Rodriguez C, Anoro E, Arroyo JA, Jerico C, Pedragosa A, la Miret M, Naf S, Pardo A, Perea V, Perez R, Plana N, Ramirez R, Royuela M, Soler C, Urquizu M, Zamora A, Pedro J, STACOV GRP. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2). DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7,1 (Q1/1D). Document type: Article.
Mir C, López BM, Pérez BS, Torrent RB, Fernández MIG, Corbeto ML, Gil JG, Zavala RG. Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria. Pediatria De Atencion Primaria. 2022; 24(94). Document type: Article.
Molina M, Castellvi I, Valenzuela C, Ramirez J, Portal J, Franquet T, Narvaez J. Management of progressive pulmonary fibrosis associated with connective tissue disease. Expert Review of Respiratory Medicine. 2022; 16(7). DOI:10.1080/17476348.2022.2107508. PMID:35912842. IF:3,9 (Q2/5D). Document type: Review.
Narváez J, Díaz del Campo Fontecha P, Brito N, Bonilla G, Aburto M, Castellví I, Cano E, Mena N, Nieto MA, Ortiz AM, Valenzuela C, Abad MÁ, Castrejón I, Correyero M, Francisco FM, Hernández MV, Rodríquez JA. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatologia Clinica. 2022; 18(9). DOI:10.1016/j.reuma.2022.03.005. PMID:36064885. Document type: Article.
Park HS, Laiz A, del Campo PD, Martinez M, Guerra M, Alonso C, Sanchez J, Corominas H. Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature. Frontiers in Medicine. 2022; 9:851483. DOI:10.3389/fmed.2022.851483. PMID:35402464. IF:3,9 (Q2/4D). Document type: Review.
Pombo M, Sanchez C, Ruiz D, Diaz C, Jovani V, Cea L, Castrejon I. Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry. Musculoskeletal Care. 2022; 20(2). DOI:10.1002/msc.1595. PMID:34668303. Document type: Article.
Pou MA, Orfila F, Pagonabarraga J, Ferrer S, Corominas H, Diaz C. Risk of Parkinson’s disease in a gout Mediterranean population: A case-control study. JOINT BONE SPINE. 2022; 89(6):105402. DOI:10.1016/j.jbspin.2022.105402. PMID:35504516. IF:4,2 (Q2/4D). Document type: Article.
Pou MA, Orfila F, Pagonabarraga J, Ferrer S, Corominas H, Diaz C. Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins. Revue Du Rhumatisme (edition Francaise). 2022; 89(6). DOI:10.1016/j.rhum.2022.09.019. Document type: Article.
Queiro R, Seoane D, Laiz A, Agirregoikoa EG, Montilla C, Park H-S, Pinto JA, Baute JJB, Ibáñez BJ, Toniolo E, Ramírez J, García AS, Proyecto REAPSER Study G. Characteristics associated with the perception of high-impact disease (PsAID =4) in patients with recent-onset psoriatic arthritis. Machine learning-based model. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 57:152097. DOI:10.1016/j.semarthrit.2022.152097. PMID:36113222. IF:5 (Q2/3D). Document type: Article.
Queiro R, Seoane D, Laiz A, Agirregoikoa EG, Montilla C, Park H-S, Pinto JA, Bethencourt JJ, Ibáñez BJ, Toniolo E, Ramírez J, García AS, Cañete JD, Juanola X, Fiter J, Gratacós J, Rodriguez J, Rosa JN, Martín AL, García AB, Segura PC, Ferrer AL, Barrio SP, Plata AJ, Bustabad S, Guimerá Martín FJ, Capdevilla EF, Díaz RR, Cuervo A, Gibert MA, Larraz PT, de la Morena I, et al., Proyecto REAPSER Study Group. Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning. ARTHRITIS RESEARCH & THERAPY. 2022; 24(1):153. DOI:10.1186/s13075-022-02838-2. PMID:35751091. IF:4,9 (Q2/4D). Document type: Article.
Queiro R, Seoane D, Laiz A, Galindez E, Montilla C, Park HS, Pinto JA, Bethencourt JJ, Joven B, Toniolo E, Ramírez J, Pruenza García C, Proyecto REAPSER Study G. Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning. Frontiers in Medicine. 2022; 9:891863. DOI:10.3389/fmed.2022.891863. PMID:35572968. IF:3,9 (Q2/4D). Document type: Article.
Quilis N, Vela P, Caceres B, Diaz C, Calvo E, Sivera F, Prada A, Ruiz FP, Pascual E, Andres M. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. ANNALS OF THE RHEUMATIC DISEASES. 2022; 81(7):e124. DOI:10.1136/annrheumdis-2020-218226. PMID:32616605. IF:27,4 (Q1/1D). Document type: Letter.
Riancho JA, Peris P, González J, Pérez JL, Cannata J, Cano A, Carbonell C, Casado E, Ciria M, Corral L, del Pino J, Del Río LM, Díaz M, Díez A, García A, Gómez C, Gómez de Tejada Romero MJ, Guañabens N, Hawkins F, Jódar E, Malouf J, Martínez Díaz G, Monegal A, Muñoz M, Naves M, Nogues X, Nolla JM, Olmos JM, Peris P, Quesada JM, Rodríguez M, Sosa M, Torrijos A, Valero Díaz de Lamadrid C, SEIOMM Osteoporosis Guidelines Writing G. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update). Revista De Osteoporosis Y Metabolismo Mineral. 2022; 14(1). DOI:10.4321/S1889-836X2022000100002. Document type: Article/Practice guideline.
Rodríguez JA, Brito N, Díaz del Campo Fontecha P, Valenzuela C, Ortiz AM, Nieto MA, Mena N, Cano E, Castellví I, Aburto M, Bonilla G, Hernández MV, Hernández FMF, Correyero M, Castrejón I, Abad MÁ, Narváez J. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatologia Clinica. 2022; 18(8). DOI:10.1016/j.reuma.2022.02.009. PMID:36085196. Document type: Article.
Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz C, Millan AM, Park HS, Lasa A, Corominas H. Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. 2022; 14(9):1942. DOI:10.3390/pharmaceutics14091942. PMID:36145690. IF:5,4 (Q1/2D). Document type: Article.
Tornero J, Alperi M, Castellvi I, de Agustin JJ, Escudero A, Garcia R, Gonzalez MA, Hidalgo C, Rubio E, Sanmarti R, Casamira N, Calvo J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1). DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. Document type: Article.
Vilchez F, Martin HB, Garcia E, Corominas H. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren’s syndrome: A critical review. Frontiers in Immunology. 2022; 13:1003054. DOI:10.3389/fimmu.2022.1003054. PMID:36325321. IF:7,3 (Q1/3D). Document type: Review.
Zozaya N, Abdalla F, Zamora SA, Filgueiras JB, Carrillo JMC, Sanchez OD, Sinisterra FD, Garcia A, Pinto PH, Manfredi A, Olmos JM, Luna PMD, Puig L, Ros S, HIdalgo A. Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 2022; 22(6). DOI:10.1080/14737167.2022.2063842. PMID:35404728. IF:2,3 (Q3/7D). Document type: Article.
Zozaya N, Arrizubieta MI, Bollo E, Castellví I, Espín J, Ortego N, Poveda JL, Rodríguez JA, Rivero A, Marcos JA, Verde L. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2022; 38(1):e64. DOI:10.1017/S0266462322000459. PMID:35912833. IF:3,2 (Q2/5D). Document type: Article.
Zozaya N, Villoro R, Abdalla F, Alfonso S, Balea J, Carrascosa JM, Delgado O, Dolz F, Garcia A, Herranz P, Manfredi A, Martinez J, Morales De los Rios Luna P, Puig L, Ros S, Hildago A. Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation. ACTA DERMATO-VENEREOLOGICA. 2022; 102:adv00678. DOI:10.2340/actadv.v102.583. PMID:35312022. IF:3,6 (Q1/3D). Document type: Article.

Publications 2021

Alegre JJ, Juanola X, Rodriguez JM, Manero J, Villa I, Laiz A, Arteaga MJ, Cea L, Gonzalez CM. Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis A retrospective study. MEDICINE. 2021; 100(13):e25223. DOI:10.1097/MD.0000000000025223. PMID:33787605. IF:1,817.
Almirall M, Martínez SH, Alegre C, Collado A, Ojeda B, Arias A, Calandre EP, Hidalgo J, Carrillo MD, Huguet R, Tornero J, Alperi M, Fernández B, Julià A, Marsal S, Arranz LI, Blanco F, Pérez C, Olivè A, Corominas H, Martínez V, González I, Erra A, López M, Sanchez S, Fernández A, Gisbert J, Domènech E, Ferrándiz C, Cañete JD, IMIDC Project Collaborative G. Dietary habits in patients with fibromyalgia: A cross-sectional study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3). PMID:34161227. IF:4,862.
Alserawan L, Penacoba P, Echevarria S, Castillo D, Ortiz E, Martinez L, Naranjo EM, Domingo P, Castellvi I, Juarez C, Mariscal A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11):1998. DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3,992.
Arroyo JA, Julve J, Vlacho B, Corcoy R, Ponte P, Roman E, Navas E, Llaurado G, Franch J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9:758347. DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6,461.
Barcelo M, Torres OH, Mascaro J, Casademont J. Hip fracture and mortality: study of specific causes of death and risk factors. Archives of Osteoporosis. 2021; 16(1):15. DOI:10.1007/s11657-020-00873-7. PMID:33452949. IF:2,879.
Cabrera J, Henriquez MS, Diaz M, Molini PS, Garcia FA, Montoya MJ, Filgueira J, Olmos JM, Coco MB, Castrillon JLP, Hernandez N, Tirado R. Profile of patients who visit medical internists for an osteoporosis assessment: The OSTEOMED registry. REVISTA CLINICA ESPANOLA. 2021; 221(1). DOI:10.1016/j.rce.2020.06.004. PMID:32682689. IF:3,064.
Cai K, Fuller A, Zhang YL, Hensey O, Grossberg D, Christensen R, Shea B, Singh JA, McCarthy GM, Rosenthal AK, Filippou G, Taylor WJ, Diaz C, Stamp LK, Edwards NL, Pascart T, Becce F, Nielsen SM, Tugwell P, Beaton D, Abhishek A, Tedeschi SK, Dalbeth N. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(4). DOI:10.1016/j.semarthrit.2021.04.019. PMID:34140183. IF:5,431.
Castillo D, Barril S, Rodrigo A, Millan P, Suarez G, Alonso A, Franquet T, Lopez L, Castellvi I, Plaza V, Sibila O. EARLY HOSPITAL READMISSION INCREASES SHORT AND LONG – TERM MORTALITY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES. 2021; 38(2):e2021021. DOI:10.36141/svdld.v38i2.10709. PMID:34316260. IF:1,803.
Corominas H, Castellvi I, Diaz C, Matas L, de la Rosa D, Mangues MA, Moya P, Pomar V, Benito N, Moga E, Hernandez N, Casademont J, Domingo P. Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. MEDICINE. 2021; 100(19):e25923. DOI:10.1097/MD.0000000000025923. PMID:34106658. IF:1,817.
Corominas H, Castellvi I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Mill AM, Quijada MA, Puig M, Casademont J, Domingo P. Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort. CLINICAL IMMUNOLOGY. 2021; 223:108631. DOI:10.1016/j.clim.2020.108631. PMID:33189888. IF:10,190.
Diaz C, Ortiz MA, Garcia A, Jeria S, Sainz L, Fernandez S, Corominas H, Vidal S. The inflammatory role of silent urate crystal deposition in intercritical gout. RHEUMATOLOGY. 2021; 60(11). DOI:10.1093/rheumatology/keab335. PMID:33839783. IF:7,046.
Díaz SM, Sánchez C, Fernández M, Andreu JL, Martínez V, Olivé A, Rosas J, Menor R, García Á, López FJ, Manrique S, García JA, López R, Narváez J, Galisteo C, González J, Naranjo A, Illera Ó, Moreira B, Raya E, Rodríguez M, Júdez E, Moriano C, Torrente V, García B, Guillén C, Castellvi I, Bohórquez C, Loricera J, Belzunegui J, Carreira PE, Sjogrenser G, Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (. Digestive involvement in primary Sjögren’s syndrome: Analysis from the Sjögrenser registry. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 38(4). PMID:33025900. IF:4,862.
Domingo P, Pomar V, Mur I, Castellvi I, Corominas H, de Benito N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7). DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13,310.
Fuller A, Cai K, Diaz C, Filippou G, Pascart T, Hensey O, Grossberg D, Christensen R, Shea B, Singh JA, Tedeschi SK, Dalbeth N, Abhishek A. Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(3). DOI:10.1016/j.semarthrit.2020.09.021. PMID:33461759. IF:5,431.
Fuller A, Cai K, Filippou G, Pascart T, Diaz C, Hensey O, Grossberg D, Christensen R, Shea B, Singh JA, Tedeschi SK, Dalbeth N, Abhishek A. Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(3). DOI:10.1016/j.semarthrit.2021.04.010. PMID:33941385. IF:5,431.
Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo A, Gras L, Fonts N. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Scientific Reports. 2021; 11(1):883. DOI:10.1038/s41598-020-80560-2. PMID:33441854. IF:4,996.
Gomis M, Perez SM, Minguell ER, Loidi VB, Lopez LL, Abarca SR, Tugas EG, Mas N, Bafalluy M. Mobile Health to Improve Adherence and Patient Experience in Heart Transplantation Recipients: The mHeart Trial. Healthcare. 2021; 9(4):463. DOI:10.3390/healthcare9040463. PMID:33919899. IF:3,160.
Julia A, Lopez M, Blanco F, Gomez A, Haro I, Mas AJ, Erra A, Vivar MLG, Monfort J, Sanchez S, Gonzalez I, Alperi M, Castellanos R, Fernandez A, Diaz C, Palau N, Lastra R, Llados J, Sanmarti R, Marsal S. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC MUSCULOSKELETAL DISORDERS. 2021; 22(1):372. DOI:10.1186/s12891-021-04248-y. PMID:33882889. IF:2,562.
Julia A, Martinez SH, Domenech E, Canete JD, Ferrandiz C, Tornero J, Gisbert JP, Fernandez A, Dauden E, Barreiro M, Perez C, Queiro R, Lopez FJ, Carazo JLS, Mendoza JL, Alperi M, Montilla C, Venegas JJP, Munoz F, Castaneda S, Lasanta ML, Marsal S, Fonseca E, Rodriguez J, Carreira P, Garcia V, Pinto JA, Puig L, Ricart E, Blanco F, Gratacos J, et al. [Garcia E, Diaz C]. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study. EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2021; 75(9). DOI:10.1038/s41430-021-00913-6. PMID:33893449. IF:4,884.
Lobo D, Corominas H, Pomar V. Suitability of serology tests for the diagnosis of Lyme disease. Single center urban cohort. MEDICINA CLINICA. 2021; 157(8). DOI:10.1016/j.medcli.2020.08.010. PMID:33279209. IF:3,200.
Magallares B, Lobo D, Castellvi I, Moya P, Gich I, Martinez L, Park H, Millan AM, Laiz A, Diaz C, Fernandez S, Corominas H. Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease. Journal of Clinical Medicine. 2021; 10(11):2377. DOI:10.3390/jcm10112377. PMID:34071275. IF:4,964.
Maher TM, Mayes MD, Kreuter M, Volkmann ER, Aringer M, Castellvi I, Cutolo M, Stock C, Schoof N, Alves M, Raghu G, SENSCIS I. Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis & Rheumatology. 2021; 73(4). DOI:10.1002/art.41576. PMID:33142016. IF:15,483.
Mariscal A, Milan M, Baucells A, Martinez MA, Guillen AG, Trallero E, Alvarado M, Martinez L, Alserawan L, Franco T, Sanz MT, Vinas L, Corominas H, Juarez C, Castellvi I, Selva A. Anti-TIF-1 gamma Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice. Frontiers in Immunology. 2021; 11:625896. DOI:10.3389/fimmu.2020.625896. PMID:33613568. IF:8,786.
Mariscal A, Zamora C, Magallares B, Salman TC, Ortiz MA, Diaz C, Castellvi I, Corominas H, Vidal S. Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(9):4719. DOI:10.3390/ijms22094719. PMID:33947017. IF:6,208.
Marron SE, Gomez M, Aragones LT, Goni A, Vilarrasa E, Diaz RM, Garcia FJ, Campos R, Fuentelsaz V, Gilaberte Y, Gracia T, Morales AM, Ros S, Madrid MB, Puig L. Quality of Life in Hidradenitis Suppurativa: Validation of the HSQoL-24. ACTA DERMATO-VENEREOLOGICA. 2021; 101:adv00529. DOI:10.2340/00015555-3905. PMID:34427316. IF:3,875.
Marsal S, Corominas H, de Agustin JJ, Perez C, Lopez M, Borrell H, Reina D, Sanmarti R, Narvaez J, Franco C, Peterfy C, Narvaez JA, Sharma V, Alataris K, Genovese MC, Baker MC. Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept study. Lancet Rheumatology. 2021; 3(4). DOI:10.1016/S2665-9913(20)30425-2. IF:35,482.
Masana L, Correig E, Ibarretxe D, Anoro E, Arroyo JA, Jerico C, Guerrero C, la Miret M, Naf S, Pardo A, Perea V, Perez R, Plana N, Ramirez R, Royuela M, Soler C, Urquizu M, Zamora A, Pedro J. Low HDL and high triglycerides predict COVID-19 severity. Scientific Reports. 2021; 11(1):7217. DOI:10.1038/s41598-021-86747-5. PMID:33785815. IF:4,996.
Morillon MB, Christensen R, Singh JA, Dalbeth N, Saag K, Taylor WJ, Neogi T, Kennedy MA, Pedersen BM, McCarthy GM, Shea B, Diaz C, Tedeschi SK, Grainger R, Abhishek A, Gaffo A, Nielsen SM, Noerup A, Simon LS, Lassere M, Tugwell P, Stamp LK, Gout Working Group FTO. Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(6). DOI:10.1016/j.semarthrit.2021.11.004. PMID:34839932. IF:5,431.
Mostaza JM, Suarez C, Cepeda JM, Manzano L, Sanchez D, Mascaró J, Maestre A. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation. BMC Cardiovascular Disorders. 2021; 21(1):384. DOI:10.1186/s12872-021-02019-0. PMID:34372782. IF:2,174.
Moya P, Leon AF, Corica ME, Marti VC, Lopez DA, Castellvi I, Corominas H. “The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica”. PLoS One. 2021; 16(9):e0255131. DOI:10.1371/journal.pone.0255131. PMID:34559822. IF:3,752.
Murillo JD, Diaz C, Ortiz MA, Coras R, Gil P, Pedersen A, Corominas H, Vidal S, Guma M. Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study. Metabolomics. 2021; 17(9):74. DOI:10.1007/s11306-021-01822-2. PMID:34402961. IF:4,747.
Park HS, Laiz A, Sanchez J, del Campo PD, Martin MA, Guerra M, Corominas H. Valve Abnormalities, Risk Factors for Heart Valve Disease and Valve Replacement Surgery in Spondyloarthritis. A Systematic Review of the Literature. Frontiers in Cardiovascular Medicine. 2021; 8:719523. DOI:10.3389/fcvm.2021.719523. PMID:34631824. IF:5,846.
Prieto D, Bernabeu P, Vela P, Narvaez J, Fernandez JC, Freire M, Gonzalez B, Solans R, Rubio JLC, Ortego N, Fernandez C, Rubio E, Garcia S, Minguez M, Fernandez C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero S, Salvatierra J, Hidalgo C, Manrique S, Romero C, Moya P, Alvarez N, Mendizabal J, Ortiz F, de Pedro IP, Alonso JL, Perez L, et al. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review. Therapeutic Advances in Musculoskeletal Disease. 2021; 13:1759720X211020917. DOI:10.1177/1759720X211020917. PMID:34211589. IF:3,625.
Prior A, Sanchez C, Campos J, Manero FJ, Perez C, Bohorquez C, Busquets N, Blanco JM, Diaz C, Sanchez F, Mateo L, Holgado S. Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry. Scientific Reports. 2021; 11(1):11091. DOI:10.1038/s41598-021-90442-w. PMID:34045525. IF:4,996.
Riancho L, Martinez V, Rua I, Alonso F, Galindo M, Ovalles J, Olive A, Vazquez NM, Calvo J, Menor R, Tomero E, Uriarte E, Botenau A, Andres M, Freire M, Soler GS, Ruiz E, Ibanez M, Castellvi I, Galisteo C, Vila VQ, Raya E, Narvaez J, Exposito L, Hernandez JA, Horcada L, Aurrecoechea E, Pego JM. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3). PMID:32828148. IF:4,862.
Sebastiani M, Luppi F, Sambataro G, Villegas DC, Cerri S, Tomietto P, Cassone G, Bocchino M, Atienza B, Cameli P, Alvarado PM, Faverio P, Bargagli E, Vancheri C, Gonzalez MA, Clini E, Salvarani C, Manfredi A. Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association. Journal of Clinical Medicine. 2021; 10(12):2548. DOI:10.3390/jcm10122548. PMID:34207641. IF:4,964.
Valero JA, Lopez R, Martin MA, Garcia C, Sanchez F, Sanchez JT, Gonzalez C, Revuelta E, Diaz C, Fernandez C, Perez C, Torrente V, Sanchez G, Perez T, Font P, Garcia ML, Aurrecoechea E, Maiz O, Valls R, Miranda JA, Llorca J, Castaneda S, Gonzalez MA, CARMA GRP. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project. Journal of Clinical Medicine. 2021; 10(3):382. DOI:10.3390/jcm10030382. PMID:33498379. IF:4,964.

2017 Scientific Report – Multi-organ Damage

Introduction

Main lines of research

Bone Metabolism and Osteoporosis

Analysis of genetic influence on osteoporosis by means of aggregation studies in families of three or more generations with a minimum of 15 members.
Bone structure study with quantitative CT of hip and spine, analysing the contribution of trabecular and cortical components using HRCT.
Description of fat values and percentages in a normal population (in collaboration with the HIV Unit and CETIR Medical Group).
Analysis of the influence of an intervention (physical exercise) on changes in the muscle compartment of patients with cirrhosis measured by DXA and HRQCT (in collaboration with the Gastroenterology Department).
Description of bone structure in patients with a history of acromegaly assessed by DXA and HRQCT.

Hypertension and Vascular Risk

Hypertension and quality of life.
Refractory hypertension.
Use of alirocumab in hypercholesterolaemia.

Clinical Management, Internal Medicine and Geriatrics

Health care quality indexes (mortality, readmissions, etc).
Perioperative medicine.
Potentially inappropriate prescribing to older patients admitted to hospital.

Rheumatology and Rheumatoid Arthritis

Early rheumatoid arthritis
Rheumatoid arthritis biomarkers
Interstitial lung disease associated with rheumatoid arthritis

Systemic sclerosis

Capillaroscopy patterns and correlation with auto-antibodies and pulmonary function tests.
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
Use of endothelin receptor antagonism to prevent pulmonary arterial hypertension (in collaboration with Vall d’Hebron University Hospital, Barcelona, Spain).
Genetic studies in systemic sclerosis and collaboration with DUO Registry and LAUDES study.
Study of capillaroscopy patterns in diffuse connective tissue diseases: QuantiCAP study.

Gout

Epidemiology of hyperuricaemia and gout.

Sjögren syndrome

TClinical and epidemiological findings in Spanish patients with primary Sjögren syndrome (in collaboration with Spanish Society of Rheumatology).

Challenges

To establish stable work relations between the HSCSP Bone Metabolism and Genomics of Complex Diseases Groups and the Bone Metabolism Unit of Hospital del Mar-Municipal Institute for Medical Research and the Faculty of Biology of the University of Barcelona.
To strengthen ties between Sant Pau’s Rheumatology and Immunology departments regarding the study of immunological diseases.

Team

Group coordination

COROMINAS MACIAS, HECTOR FGS
hcorominas@santpau.cat

Members

Scientific output

Publications 2023

(JIF 2023)

-Casademont J. Physical examination today. MEDICINA CLINICA. 2023; 160(12). DOI:10.1016/j.medcli.2023.02.001. PMID:36907715. IF:2,600 (Q1/3D). Document type: Editorial Material.

Publications 2022

(JIF 2022)

Alvarado PM, de Oro JJD, Espinar MA, Perez EA, Perez NB, Carmona L, Burgos EC, Poch TC, Aguilera AC, Mendieta ED, Alarcon PE, Casares EG, Perez SH, Lopez BM, Morillo MM, Soria LM, Pastor CM, Martinez MM, Fernandez AP, Busquets MP, Garcia JR, Sanz DR, Lizarzaburu MS, Santo Panero P, Alierta ES, Roc MV, Macias HC. Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists. RHEUMATOLOGY INTERNATIONAL. 2022; 42(3). DOI:10.1007/s00296-020-04733-y. PMID:33146762. IF:4 (Q2/5D). Document type: Article.
Balius R, Pujol M, Perez D, Morros C, Susin A, Corominas H, Sala X. Sciatic nerve movement in the deep gluteal space during hip rotations maneuvers. CLINICAL ANATOMY. 2022; 35(4). DOI:10.1002/ca.23828. PMID:34913517. IF:2,4 (Q2/4D). Document type: Article.
Balsa A, González I, Sanmartí R, Corominas H. How do Spanish Rheumatologists handle remission? Survey of knowledge and approach before and after a training workshop. Reumatologia Clinica. 2022; 18(9). DOI:10.1016/j.reuma.2021.08.002, DOI (English Edition):10.1016/j.reumae.2021.08.002. PMID:34489191. Document type: Letter.
Calabria M, Garcia C, Grunden N, Pons C, Arroyo JA, Gomez B, Garcia M, Belvis R, Morollon N, Igual JV, Mur I, Pomar V, Domingo P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. JOURNAL OF NEUROLOGY. 2022; 269(8). DOI:10.1007/s00415-022-11141-8. PMID:35488918. IF:6 (Q1/2D). Document type: Article.
Calvo J, Pou J. Continuing medical education. An opportunity to continue improving. MEDICINA CLINICA. 2022; 159(1). DOI:10.1016/j.medcli.2022.03.012. PMID:35636993. IF:3,9 (Q2/4D). Document type: Editorial material.
Castellvi I, Castillo D, Corominas H, Mariscal A, Orozco S, Benito N, Pomar V, Baucells A, Mur I, de la Rosa D, Lobo D, Millan AM, de Sosa NH, Filella D, Matas L, Martinez L, Juarez C, Casademont J, Domingo P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9:973918. DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3,9 (Q2/4D). Document type: Article.
Castellví I, Vidal S, Valenzuela C. Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8). DOI:10.1016/j.arbres.2021.08.016. PMID:35312568. IF:8 (Q1/2D). Document type: Editorial material.
Cendon L, Rafecas A, De La Rosa D, Castellví I, Spagnolo P, Castillo D. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia. Open Respiratory Archives. 2022; 4(4):100211. DOI:10.1016/j.opresp.2022.100211. Document type: Article.
Cobo T, Sánchez C, Nuño L, Castellví I, Carrión I, Romero F, Narváez J, Trallero E, Tomero E, Ruiz ME, Larena C, Carrasco C, Jovaní V, Barbadillo C, Sivera F, Belzunegui J, Pérez A, Gómez A, Delgado E, Pego JM, Joven B, Ibáñez M, Martínez O, Ruiz A, Camins J, Ortega R, Trenor P, Rodríguez M, Freire M, Alcocer P, Holgado S, Rúa I, Lozano N, Martínez J. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatologia Clinica. 2022; 18(5). DOI:10.1016/j.reuma.2021.01.007. PMID:33867271. Document type: Article.
de la Calle C, Rodriguez J, Ciudad L, Ramirez J, Celis R, Azuaga AB, Cuervo A, Graell E, Perez C, Diaz C, Salvador G, Gomez JA, Haro I, Sanmarti R, Canete JD, Ballestar E. The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis. JCI Insight. 2022; 7(9):e158783. DOI:10.1172/jci.insight.158783. PMID:35324478. IF:8 (Q1/2D). Document type: Article.
De Miguel E, Sanchez JT, Estrada P, Munoz A, Martinez CV, Alvarado PM, Garcia MJ, Angeles V, Da CGL, Frutos AR, Ivorra J, Arrabal SL, Rocha MV, Iniguez CL, Garcia M, Molina C, Villar MA, Mas AJ, Gonzalez MA, Blanco R. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register. RMD Open. 2022; 8(2):e002507. DOI:10.1136/rmdopen-2022-002507. PMID:36597988. IF:6,2 (Q1/2D). Document type: Article.
Fernández SP, Rodríguez F, Laiz A, Castellví I, Magallares B, Corominas H. Impact of the COVID-19 pandemic on rheumatology nursing consultation. Reumatologia Clinica. 2022; 18(4). DOI:10.1016/j.reuma.2021.02.003. PMID:34088653. Document type: Article.
Franco T, Torres OH, Saez ME, Boera G, Santos Á, Clotet S, Albert D, El Y, Agustí M, Casademont J, Juárez C, Martínez L. Early differentiated CD28(+) CD27(+) T lymphocytes as a biomarker for short and long-term outcomes in older patients with pneumonia. JOURNAL OF LEUKOCYTE BIOLOGY. 2022; 112(5). DOI:10.1002/JLB.5MA0422-370R. PMID:35748037. IF:5,5 (Q2/3D). Document type: Article.
Galindo R, Bou R, Mir C, Martínez S, Magallares B, López M. Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children. ANALES DE PEDIATRIA. 2022; 97(3). DOI:10.1016/j.anpedi.2021.09.008. PMID:35915035. IF:2,1 (Q3/6D). Document type: Article.
Garcia C, Calabria M, Grunden N, Pons C, Arroyo JA, Gomez B, Lleo A, Alcolea D, Belvis R, Morollon N, Mur I, Pomar V, Domingo P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain and Behavior. 2022; 12(3):e2508. DOI:10.1002/brb3.2508. PMID:35137561. IF:3,1 (Q2/3D). Document type: Article.
Gomez JA, Lobo D, Perez C, Ponce A, Frade B, Arciniegas A, Ojeda F, Ruiz V, Corominas H. Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study. Frontiers in Medicine. 2022; 9:888377. DOI:10.3389/fmed.2022.888377. PMID:35783644. IF:3,9 (Q2/4D). Document type: Article.
Hemmig AK, Gozzoli D, Werlen L, Ewald H, Aschwanden M, Blockmans D, Brouwer E, Buchanan RRC, Camellino D, Campochiaro C, Cimmino MA, Corominas H, Gloy V, Henckaerts L, Kyburz D, Moya P, Owen CE, Stegert M, Tomelleri A, van Y, Yamashita H, Imfeld S, Berger CT, Hemkens LG, Daikeler T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 55:152017. DOI:10.1016/j.semarthrit.2022.152017. PMID:35537222. IF:5 (Q2/3D). Document type: Review.
Hernández B, Rosas J, Díaz C, Belzunegui J, García R, Inciarte J, Pons A, Millán AM, Jeria S, Valero JA, García N, Valero C, Llorente I, Calvo A, Díaz S, Núñez M. Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study). Rheumatology and Therapy. 2022; 9(2). DOI:10.1007/s40744-021-00423-8. IF:3,8 (Q3/6D). Document type: Article.
Julia A, Gomez A, Lopez M, Blanco F, Erra A, Fernandez A, Mas AJ, Perez C, Vivar MLG, Sanchez S, Alperi M, Sanmarti R, Ortiz AM, Fernandez CM, Diaz C, Moreno E, Li TL, Martinez SH, Absher DM, Myers RM, Molina JT, Marsal S. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. 2022; 80:104053. DOI:10.1016/j.ebiom.2022.104053. PMID:35576644. IF:11,1 (Q1/1D). Document type: Article.
Kerick M, Acosta M, Simeón CP, Callejas JL, Assassi S, Carreira P, Castellvi I, Ríos R, Portales RG, Fernández A, García FJ, Aguirre MA, Fernández B, Rodríguez L, de la Peña PG, Vicente E, Andreu JL, de Castro MF, López FJ, Fonollosa V, Guillén A, Tolosa C, Pros A, Beltrán E, Carballeira MR, Narváez FJ, Rivas MR, Ortiz V, Madroñero AB, González MA, Díaz B, Trapiella L, et al., International SSC Group, Australian Scleroderma Interest Group, PRECISESADS Clinical Consortium. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. npj Genomic Medicine. 2022; 7(1):57. DOI:10.1038/s41525-022-00327-8. PMID:36198672. IF:5,3 (Q1/2D). Document type: Article.
Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, Vettori S, Siegert E, Rednic S, Codullo V, Airo P, Braun Y, Hunzelmann N, Joao M, Riccieri V, Gheorghiu A-M, Alegre JJ, Romanowska K, Castellví I, Kötter I, Truchetet M-E, López FJ, Novikov PI, Giollo A, Shirai Y, Belloli L, Zanatta E, Hachulla E, Smith V, Denton C, Ionescu RM, Schmeiser T, Distler JHW, Gabrielli A, Hoffmann A-M, Kuwana M, Allanore Y, Distler O. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open. 2022; 8(2):e002477. DOI:10.1136/rmdopen-2022-002477. PMID:36328401. IF:6,2 (Q1/2D). Document type: Article.
Lopez A, Laiz A, Puig L. Psoriatic arthritis. MEDICINA CLINICA. 2022; 159(1). DOI:10.1016/j.medcli.2022.01.024. PMID:35525675. IF:3,9 (Q2/4D). Document type: Review.
Mariscal A, Zamora C, Diaz C, Ortiz MA, de Agustin JJ, Reina D, Estrada P, Moya P, Corominas H, Vidal S. Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(10):5748. DOI:10.3390/ijms23105748. PMID:35628558. IF:5,6 (Q1/3D). Document type: Article.
Marquès M, Correig E, Ibarretxe D, Anoro E, Antonio J, Jericó C, Borrallo RM, Miret M, Näf S, Pardo A, Perea V, Pérez R, Ramírez R, Royuela M, Soler C, Urquizu M, Zamora A, Pedro J, Masana L, Domingo JL, STACOV G. Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality. ENVIRONMENT INTERNATIONAL. 2022; 158:106930. DOI:10.1016/j.envint.2021.106930. PMID:34678637. IF:11,8 (Q1/1D). Document type: Article.
Martin JL, Sanchez L, Calvo V, Adan A, Hernanz I, Gallego A, Beltran E, Castro S, Fanlo P, Martos AG, Torre I, Cordero M, De Dios JR, Garcia A, Hernandez M, Sanchez A, Garcia A, Maiz O, Miguelez R, Rodriguez S, Urruticoechea A, Veroz R, Conesa A, Fernandez C, Jovani V, Mondejar JJ, Gonzalez OM, Alvarado PM, Romero S, Rubio P, Pena E, Garijo M, Demetrio R, Hernandez JL, Blanco R. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients. RMD Open. 2022; 8(2):e002693. DOI:10.1136/rmdopen-2022-002693. PMID:36597972. IF:6,2 (Q1/2D). Document type: Article.
Masana L, Correig E, Rodriguez C, Anoro E, Arroyo JA, Jerico C, Pedragosa A, la Miret M, Naf S, Pardo A, Perea V, Perez R, Plana N, Ramirez R, Royuela M, Soler C, Urquizu M, Zamora A, Pedro J, STACOV GRP. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2). DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7,1 (Q1/1D). Document type: Article.
Mir C, López BM, Pérez BS, Torrent RB, Fernández MIG, Corbeto ML, Gil JG, Zavala RG. Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria. Pediatria De Atencion Primaria. 2022; 24(94). Document type: Article.
Molina M, Castellvi I, Valenzuela C, Ramirez J, Portal J, Franquet T, Narvaez J. Management of progressive pulmonary fibrosis associated with connective tissue disease. Expert Review of Respiratory Medicine. 2022; 16(7). DOI:10.1080/17476348.2022.2107508. PMID:35912842. IF:3,9 (Q2/5D). Document type: Review.
Narváez J, Díaz del Campo Fontecha P, Brito N, Bonilla G, Aburto M, Castellví I, Cano E, Mena N, Nieto MA, Ortiz AM, Valenzuela C, Abad MÁ, Castrejón I, Correyero M, Francisco FM, Hernández MV, Rodríquez JA. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatologia Clinica. 2022; 18(9). DOI:10.1016/j.reuma.2022.03.005. PMID:36064885. Document type: Article.
Park HS, Laiz A, del Campo PD, Martinez M, Guerra M, Alonso C, Sanchez J, Corominas H. Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature. Frontiers in Medicine. 2022; 9:851483. DOI:10.3389/fmed.2022.851483. PMID:35402464. IF:3,9 (Q2/4D). Document type: Review.
Pombo M, Sanchez C, Ruiz D, Diaz C, Jovani V, Cea L, Castrejon I. Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry. Musculoskeletal Care. 2022; 20(2). DOI:10.1002/msc.1595. PMID:34668303. Document type: Article.
Pou MA, Orfila F, Pagonabarraga J, Ferrer S, Corominas H, Diaz C. Risk of Parkinson’s disease in a gout Mediterranean population: A case-control study. JOINT BONE SPINE. 2022; 89(6):105402. DOI:10.1016/j.jbspin.2022.105402. PMID:35504516. IF:4,2 (Q2/4D). Document type: Article.
Pou MA, Orfila F, Pagonabarraga J, Ferrer S, Corominas H, Diaz C. Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins. Revue Du Rhumatisme (edition Francaise). 2022; 89(6). DOI:10.1016/j.rhum.2022.09.019. Document type: Article.
Queiro R, Seoane D, Laiz A, Agirregoikoa EG, Montilla C, Park H-S, Pinto JA, Baute JJB, Ibáñez BJ, Toniolo E, Ramírez J, García AS, Proyecto REAPSER Study G. Characteristics associated with the perception of high-impact disease (PsAID =4) in patients with recent-onset psoriatic arthritis. Machine learning-based model. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 57:152097. DOI:10.1016/j.semarthrit.2022.152097. PMID:36113222. IF:5 (Q2/3D). Document type: Article.
Queiro R, Seoane D, Laiz A, Agirregoikoa EG, Montilla C, Park H-S, Pinto JA, Bethencourt JJ, Ibáñez BJ, Toniolo E, Ramírez J, García AS, Cañete JD, Juanola X, Fiter J, Gratacós J, Rodriguez J, Rosa JN, Martín AL, García AB, Segura PC, Ferrer AL, Barrio SP, Plata AJ, Bustabad S, Guimerá Martín FJ, Capdevilla EF, Díaz RR, Cuervo A, Gibert MA, Larraz PT, de la Morena I, et al., Proyecto REAPSER Study Group. Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning. ARTHRITIS RESEARCH & THERAPY. 2022; 24(1):153. DOI:10.1186/s13075-022-02838-2. PMID:35751091. IF:4,9 (Q2/4D). Document type: Article.
Queiro R, Seoane D, Laiz A, Galindez E, Montilla C, Park HS, Pinto JA, Bethencourt JJ, Joven B, Toniolo E, Ramírez J, Pruenza García C, Proyecto REAPSER Study G. Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning. Frontiers in Medicine. 2022; 9:891863. DOI:10.3389/fmed.2022.891863. PMID:35572968. IF:3,9 (Q2/4D). Document type: Article.
Quilis N, Vela P, Caceres B, Diaz C, Calvo E, Sivera F, Prada A, Ruiz FP, Pascual E, Andres M. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. ANNALS OF THE RHEUMATIC DISEASES. 2022; 81(7):e124. DOI:10.1136/annrheumdis-2020-218226. PMID:32616605. IF:27,4 (Q1/1D). Document type: Letter.
Riancho JA, Peris P, González J, Pérez JL, Cannata J, Cano A, Carbonell C, Casado E, Ciria M, Corral L, del Pino J, Del Río LM, Díaz M, Díez A, García A, Gómez C, Gómez de Tejada Romero MJ, Guañabens N, Hawkins F, Jódar E, Malouf J, Martínez Díaz G, Monegal A, Muñoz M, Naves M, Nogues X, Nolla JM, Olmos JM, Peris P, Quesada JM, Rodríguez M, Sosa M, Torrijos A, Valero Díaz de Lamadrid C, SEIOMM Osteoporosis Guidelines Writing G. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update). Revista De Osteoporosis Y Metabolismo Mineral. 2022; 14(1). DOI:10.4321/S1889-836X2022000100002. Document type: Article/Practice guideline.
Rodríguez JA, Brito N, Díaz del Campo Fontecha P, Valenzuela C, Ortiz AM, Nieto MA, Mena N, Cano E, Castellví I, Aburto M, Bonilla G, Hernández MV, Hernández FMF, Correyero M, Castrejón I, Abad MÁ, Narváez J. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatologia Clinica. 2022; 18(8). DOI:10.1016/j.reuma.2022.02.009. PMID:36085196. Document type: Article.
Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz C, Millan AM, Park HS, Lasa A, Corominas H. Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. 2022; 14(9):1942. DOI:10.3390/pharmaceutics14091942. PMID:36145690. IF:5,4 (Q1/2D). Document type: Article.
Tornero J, Alperi M, Castellvi I, de Agustin JJ, Escudero A, Garcia R, Gonzalez MA, Hidalgo C, Rubio E, Sanmarti R, Casamira N, Calvo J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1). DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. Document type: Article.
Vilchez F, Martin HB, Garcia E, Corominas H. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren’s syndrome: A critical review. Frontiers in Immunology. 2022; 13:1003054. DOI:10.3389/fimmu.2022.1003054. PMID:36325321. IF:7,3 (Q1/3D). Document type: Review.
Zozaya N, Abdalla F, Zamora SA, Filgueiras JB, Carrillo JMC, Sanchez OD, Sinisterra FD, Garcia A, Pinto PH, Manfredi A, Olmos JM, Luna PMD, Puig L, Ros S, HIdalgo A. Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 2022; 22(6). DOI:10.1080/14737167.2022.2063842. PMID:35404728. IF:2,3 (Q3/7D). Document type: Article.
Zozaya N, Arrizubieta MI, Bollo E, Castellví I, Espín J, Ortego N, Poveda JL, Rodríguez JA, Rivero A, Marcos JA, Verde L. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2022; 38(1):e64. DOI:10.1017/S0266462322000459. PMID:35912833. IF:3,2 (Q2/5D). Document type: Article.
Zozaya N, Villoro R, Abdalla F, Alfonso S, Balea J, Carrascosa JM, Delgado O, Dolz F, Garcia A, Herranz P, Manfredi A, Martinez J, Morales De los Rios Luna P, Puig L, Ros S, Hildago A. Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation. ACTA DERMATO-VENEREOLOGICA. 2022; 102:adv00678. DOI:10.2340/actadv.v102.583. PMID:35312022. IF:3,6 (Q1/3D). Document type: Article.

Publications 2021

Alegre JJ, Juanola X, Rodriguez JM, Manero J, Villa I, Laiz A, Arteaga MJ, Cea L, Gonzalez CM. Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis A retrospective study. MEDICINE. 2021; 100(13):e25223. DOI:10.1097/MD.0000000000025223. PMID:33787605. IF:1,817.
Almirall M, Martínez SH, Alegre C, Collado A, Ojeda B, Arias A, Calandre EP, Hidalgo J, Carrillo MD, Huguet R, Tornero J, Alperi M, Fernández B, Julià A, Marsal S, Arranz LI, Blanco F, Pérez C, Olivè A, Corominas H, Martínez V, González I, Erra A, López M, Sanchez S, Fernández A, Gisbert J, Domènech E, Ferrándiz C, Cañete JD, IMIDC Project Collaborative G. Dietary habits in patients with fibromyalgia: A cross-sectional study. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3). PMID:34161227. IF:4,862.
Alserawan L, Penacoba P, Echevarria S, Castillo D, Ortiz E, Martinez L, Naranjo EM, Domingo P, Castellvi I, Juarez C, Mariscal A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11):1998. DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3,992.
Arroyo JA, Julve J, Vlacho B, Corcoy R, Ponte P, Roman E, Navas E, Llaurado G, Franch J, Domingo P, Mauricio D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9:758347. DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6,461.
Barcelo M, Torres OH, Mascaro J, Casademont J. Hip fracture and mortality: study of specific causes of death and risk factors. Archives of Osteoporosis. 2021; 16(1):15. DOI:10.1007/s11657-020-00873-7. PMID:33452949. IF:2,879.
Cabrera J, Henriquez MS, Diaz M, Molini PS, Garcia FA, Montoya MJ, Filgueira J, Olmos JM, Coco MB, Castrillon JLP, Hernandez N, Tirado R. Profile of patients who visit medical internists for an osteoporosis assessment: The OSTEOMED registry. REVISTA CLINICA ESPANOLA. 2021; 221(1). DOI:10.1016/j.rce.2020.06.004. PMID:32682689. IF:3,064.
Cai K, Fuller A, Zhang YL, Hensey O, Grossberg D, Christensen R, Shea B, Singh JA, McCarthy GM, Rosenthal AK, Filippou G, Taylor WJ, Diaz C, Stamp LK, Edwards NL, Pascart T, Becce F, Nielsen SM, Tugwell P, Beaton D, Abhishek A, Tedeschi SK, Dalbeth N. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(4). DOI:10.1016/j.semarthrit.2021.04.019. PMID:34140183. IF:5,431.
Castillo D, Barril S, Rodrigo A, Millan P, Suarez G, Alonso A, Franquet T, Lopez L, Castellvi I, Plaza V, Sibila O. EARLY HOSPITAL READMISSION INCREASES SHORT AND LONG – TERM MORTALITY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES. 2021; 38(2):e2021021. DOI:10.36141/svdld.v38i2.10709. PMID:34316260. IF:1,803.
Corominas H, Castellvi I, Diaz C, Matas L, de la Rosa D, Mangues MA, Moya P, Pomar V, Benito N, Moga E, Hernandez N, Casademont J, Domingo P. Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2. MEDICINE. 2021; 100(19):e25923. DOI:10.1097/MD.0000000000025923. PMID:34106658. IF:1,817.
Corominas H, Castellvi I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Mill AM, Quijada MA, Puig M, Casademont J, Domingo P. Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort. CLINICAL IMMUNOLOGY. 2021; 223:108631. DOI:10.1016/j.clim.2020.108631. PMID:33189888. IF:10,190.
Diaz C, Ortiz MA, Garcia A, Jeria S, Sainz L, Fernandez S, Corominas H, Vidal S. The inflammatory role of silent urate crystal deposition in intercritical gout. RHEUMATOLOGY. 2021; 60(11). DOI:10.1093/rheumatology/keab335. PMID:33839783. IF:7,046.
Díaz SM, Sánchez C, Fernández M, Andreu JL, Martínez V, Olivé A, Rosas J, Menor R, García Á, López FJ, Manrique S, García JA, López R, Narváez J, Galisteo C, González J, Naranjo A, Illera Ó, Moreira B, Raya E, Rodríguez M, Júdez E, Moriano C, Torrente V, García B, Guillén C, Castellvi I, Bohórquez C, Loricera J, Belzunegui J, Carreira PE, Sjogrenser G, Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (. Digestive involvement in primary Sjögren’s syndrome: Analysis from the Sjögrenser registry. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 38(4). PMID:33025900. IF:4,862.
Domingo P, Pomar V, Mur I, Castellvi I, Corominas H, de Benito N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7). DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13,310.
Fuller A, Cai K, Diaz C, Filippou G, Pascart T, Hensey O, Grossberg D, Christensen R, Shea B, Singh JA, Tedeschi SK, Dalbeth N, Abhishek A. Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(3). DOI:10.1016/j.semarthrit.2020.09.021. PMID:33461759. IF:5,431.
Fuller A, Cai K, Filippou G, Pascart T, Diaz C, Hensey O, Grossberg D, Christensen R, Shea B, Singh JA, Tedeschi SK, Dalbeth N, Abhishek A. Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(3). DOI:10.1016/j.semarthrit.2021.04.010. PMID:33941385. IF:5,431.
Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo A, Gras L, Fonts N. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Scientific Reports. 2021; 11(1):883. DOI:10.1038/s41598-020-80560-2. PMID:33441854. IF:4,996.
Gomis M, Perez SM, Minguell ER, Loidi VB, Lopez LL, Abarca SR, Tugas EG, Mas N, Bafalluy M. Mobile Health to Improve Adherence and Patient Experience in Heart Transplantation Recipients: The mHeart Trial. Healthcare. 2021; 9(4):463. DOI:10.3390/healthcare9040463. PMID:33919899. IF:3,160.
Julia A, Lopez M, Blanco F, Gomez A, Haro I, Mas AJ, Erra A, Vivar MLG, Monfort J, Sanchez S, Gonzalez I, Alperi M, Castellanos R, Fernandez A, Diaz C, Palau N, Lastra R, Llados J, Sanmarti R, Marsal S. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC MUSCULOSKELETAL DISORDERS. 2021; 22(1):372. DOI:10.1186/s12891-021-04248-y. PMID:33882889. IF:2,562.
Julia A, Martinez SH, Domenech E, Canete JD, Ferrandiz C, Tornero J, Gisbert JP, Fernandez A, Dauden E, Barreiro M, Perez C, Queiro R, Lopez FJ, Carazo JLS, Mendoza JL, Alperi M, Montilla C, Venegas JJP, Munoz F, Castaneda S, Lasanta ML, Marsal S, Fonseca E, Rodriguez J, Carreira P, Garcia V, Pinto JA, Puig L, Ricart E, Blanco F, Gratacos J, et al. [Garcia E, Diaz C]. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study. EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2021; 75(9). DOI:10.1038/s41430-021-00913-6. PMID:33893449. IF:4,884.
Lobo D, Corominas H, Pomar V. Suitability of serology tests for the diagnosis of Lyme disease. Single center urban cohort. MEDICINA CLINICA. 2021; 157(8). DOI:10.1016/j.medcli.2020.08.010. PMID:33279209. IF:3,200.
Magallares B, Lobo D, Castellvi I, Moya P, Gich I, Martinez L, Park H, Millan AM, Laiz A, Diaz C, Fernandez S, Corominas H. Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease. Journal of Clinical Medicine. 2021; 10(11):2377. DOI:10.3390/jcm10112377. PMID:34071275. IF:4,964.
Maher TM, Mayes MD, Kreuter M, Volkmann ER, Aringer M, Castellvi I, Cutolo M, Stock C, Schoof N, Alves M, Raghu G, SENSCIS I. Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis & Rheumatology. 2021; 73(4). DOI:10.1002/art.41576. PMID:33142016. IF:15,483.
Mariscal A, Milan M, Baucells A, Martinez MA, Guillen AG, Trallero E, Alvarado M, Martinez L, Alserawan L, Franco T, Sanz MT, Vinas L, Corominas H, Juarez C, Castellvi I, Selva A. Anti-TIF-1 gamma Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice. Frontiers in Immunology. 2021; 11:625896. DOI:10.3389/fimmu.2020.625896. PMID:33613568. IF:8,786.
Mariscal A, Zamora C, Magallares B, Salman TC, Ortiz MA, Diaz C, Castellvi I, Corominas H, Vidal S. Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(9):4719. DOI:10.3390/ijms22094719. PMID:33947017. IF:6,208.
Marron SE, Gomez M, Aragones LT, Goni A, Vilarrasa E, Diaz RM, Garcia FJ, Campos R, Fuentelsaz V, Gilaberte Y, Gracia T, Morales AM, Ros S, Madrid MB, Puig L. Quality of Life in Hidradenitis Suppurativa: Validation of the HSQoL-24. ACTA DERMATO-VENEREOLOGICA. 2021; 101:adv00529. DOI:10.2340/00015555-3905. PMID:34427316. IF:3,875.
Marsal S, Corominas H, de Agustin JJ, Perez C, Lopez M, Borrell H, Reina D, Sanmarti R, Narvaez J, Franco C, Peterfy C, Narvaez JA, Sharma V, Alataris K, Genovese MC, Baker MC. Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept study. Lancet Rheumatology. 2021; 3(4). DOI:10.1016/S2665-9913(20)30425-2. IF:35,482.
Masana L, Correig E, Ibarretxe D, Anoro E, Arroyo JA, Jerico C, Guerrero C, la Miret M, Naf S, Pardo A, Perea V, Perez R, Plana N, Ramirez R, Royuela M, Soler C, Urquizu M, Zamora A, Pedro J. Low HDL and high triglycerides predict COVID-19 severity. Scientific Reports. 2021; 11(1):7217. DOI:10.1038/s41598-021-86747-5. PMID:33785815. IF:4,996.
Morillon MB, Christensen R, Singh JA, Dalbeth N, Saag K, Taylor WJ, Neogi T, Kennedy MA, Pedersen BM, McCarthy GM, Shea B, Diaz C, Tedeschi SK, Grainger R, Abhishek A, Gaffo A, Nielsen SM, Noerup A, Simon LS, Lassere M, Tugwell P, Stamp LK, Gout Working Group FTO. Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021; 51(6). DOI:10.1016/j.semarthrit.2021.11.004. PMID:34839932. IF:5,431.
Mostaza JM, Suarez C, Cepeda JM, Manzano L, Sanchez D, Mascaró J, Maestre A. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation. BMC Cardiovascular Disorders. 2021; 21(1):384. DOI:10.1186/s12872-021-02019-0. PMID:34372782. IF:2,174.
Moya P, Leon AF, Corica ME, Marti VC, Lopez DA, Castellvi I, Corominas H. “The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica”. PLoS One. 2021; 16(9):e0255131. DOI:10.1371/journal.pone.0255131. PMID:34559822. IF:3,752.
Murillo JD, Diaz C, Ortiz MA, Coras R, Gil P, Pedersen A, Corominas H, Vidal S, Guma M. Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study. Metabolomics. 2021; 17(9):74. DOI:10.1007/s11306-021-01822-2. PMID:34402961. IF:4,747.
Park HS, Laiz A, Sanchez J, del Campo PD, Martin MA, Guerra M, Corominas H. Valve Abnormalities, Risk Factors for Heart Valve Disease and Valve Replacement Surgery in Spondyloarthritis. A Systematic Review of the Literature. Frontiers in Cardiovascular Medicine. 2021; 8:719523. DOI:10.3389/fcvm.2021.719523. PMID:34631824. IF:5,846.
Prieto D, Bernabeu P, Vela P, Narvaez J, Fernandez JC, Freire M, Gonzalez B, Solans R, Rubio JLC, Ortego N, Fernandez C, Rubio E, Garcia S, Minguez M, Fernandez C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero S, Salvatierra J, Hidalgo C, Manrique S, Romero C, Moya P, Alvarez N, Mendizabal J, Ortiz F, de Pedro IP, Alonso JL, Perez L, et al. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review. Therapeutic Advances in Musculoskeletal Disease. 2021; 13:1759720X211020917. DOI:10.1177/1759720X211020917. PMID:34211589. IF:3,625.
Prior A, Sanchez C, Campos J, Manero FJ, Perez C, Bohorquez C, Busquets N, Blanco JM, Diaz C, Sanchez F, Mateo L, Holgado S. Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry. Scientific Reports. 2021; 11(1):11091. DOI:10.1038/s41598-021-90442-w. PMID:34045525. IF:4,996.
Riancho L, Martinez V, Rua I, Alonso F, Galindo M, Ovalles J, Olive A, Vazquez NM, Calvo J, Menor R, Tomero E, Uriarte E, Botenau A, Andres M, Freire M, Soler GS, Ruiz E, Ibanez M, Castellvi I, Galisteo C, Vila VQ, Raya E, Narvaez J, Exposito L, Hernandez JA, Horcada L, Aurrecoechea E, Pego JM. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3). PMID:32828148. IF:4,862.
Sebastiani M, Luppi F, Sambataro G, Villegas DC, Cerri S, Tomietto P, Cassone G, Bocchino M, Atienza B, Cameli P, Alvarado PM, Faverio P, Bargagli E, Vancheri C, Gonzalez MA, Clini E, Salvarani C, Manfredi A. Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association. Journal of Clinical Medicine. 2021; 10(12):2548. DOI:10.3390/jcm10122548. PMID:34207641. IF:4,964.
Valero JA, Lopez R, Martin MA, Garcia C, Sanchez F, Sanchez JT, Gonzalez C, Revuelta E, Diaz C, Fernandez C, Perez C, Torrente V, Sanchez G, Perez T, Font P, Garcia ML, Aurrecoechea E, Maiz O, Valls R, Miranda JA, Llorca J, Castaneda S, Gonzalez MA, CARMA GRP. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project. Journal of Clinical Medicine. 2021; 10(3):382. DOI:10.3390/jcm10030382. PMID:33498379. IF:4,964.

TRANSLATIONAL MEDICINE

Multi-organ Damage and Rheumatology

Main lines of research

Bone Metabolism and Osteoporosis

Hypertension and Vascular Risk

Clinical Management, Internal Medicine and Geriatrics

Rheumatology and Rheumatoid Arthritis

Systemic sclerosis

Gout

Sjögren syndrome

Challenges

Group coordination

Members

Publications 2023

Publications 2022

Publications 2021

Main lines of research

Bone Metabolism and Osteoporosis

Hypertension and Vascular Risk

Clinical Management, Internal Medicine and Geriatrics

Rheumatology and Rheumatoid Arthritis

Systemic sclerosis

Gout

Sjögren syndrome

Challenges

Group coordination

Members

Publications 2023

Publications 2022

Publications 2021

Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau